Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emme is a women's health digital health company best known for its connected birth control adherence product, the Emme Smart Case, paired with a mobile app. The system automatically tracks oral contraceptive use and sends personalized reminders intended to reduce missed pills and improve adherence. Emme launched commercially in 2020 and positioned itself in femtech and reproductive health rather than as a therapeutics developer. In February 2022, Emme was acquired by SimpleHealth to expand integrated reproductive healthcare offerings. The Emme brand and website remain active, but the company is best understood as an acquired healthtech business rather than an independent biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emme.